Clinical Trial Update: Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of imlifidase desensitization in highly sensitized kidney transplant patients, including two non-compara…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Imlifidase (imlifidase)

Snippet

Sponsor: Hansa Biopharma AB | Conditions: Kidney Transplantation in Highly Sensitized Patients | Phase 3 | Status: ACTIVE_NOT_RECRUITING